Navigating 4 Analyst Ratings For Bio-Techne
Navigating 4 Analyst Ratings For Bio-Techne
浏览 Bio-Techne 的 4 个分析师评级
In the preceding three months, 4 analysts have released ratings for Bio-Techne (NASDAQ:TECH), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有4位分析师发布了Bio-Techne（纳斯达克股票代码：TECH）的评级，提出了从看涨到看跌的各种观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $77.25, along with a high estimate of $87.00 and a low estimate of $65.00. Experiencing a 11.54% decline, the current average is now lower than the previous average price target of $87.33.
分析师提供了更深入的见解，确定了12个月的目标股价，平均目标价为77.25美元，最高估计为87.00美元，低估值为65.00美元。目前的平均价格下降了11.54％，现在低于之前的平均目标股价87.33美元。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
A comprehensive examination of how financial experts...
对金融专家如何...
登录免费看全文
登录/注册